Transplant Physicians’ Attitudes on Candidacy for Allogeneic Hematopoietic Cell Transplantation (HCT) in Older Patients: The Need for a Standardized Geriatric Assessment (GA) Tool
Asmita Mishra(Moffitt Cancer Center), Andrew Artz, Zack DeFilipp(Massachusetts General Hospital), Christopher Bredeson, Mohamed L. Sorror(University of Washington Medical Center), William A. Wood(University of North Carolina at Chapel Hill), Ashley Rosko(The Ohio State University), Laura C. Michaelis(Medical College of Wisconsin), Richard J. Lin(Cornell University), Lyndsey Runaas(Medical College of Wisconsin), Saurabh Chhabra(Medical College of Wisconsin), Thuy T. Koll, Eileen Danaher Hacker, Ann A. Jakubowski(Memorial Sloan Kettering Cancer Center), Reena Jayani(Vanderbilt University Medical Center), Anita D’Souza, Leyla Shune(University of Kansas Medical Center), Nitya Nathwani(City of Hope), Laura Johnston(Stanford Medicine), Shahrukh K. Hashmi(Mayo Clinic), Parastoo B. Dahi(Memorial Sloan Kettering Cancer Center), Vijaya Raj Bhatt(Susan Thompson Buffett Foundation), Anthony D. Sung(Duke University), Mitchell Sabloff(University of Ottawa), Uday Popat(The University of Texas MD Anderson Cancer Center), Veronika Bachanová(University of Minnesota), Shannon R. McCurdy(Hospital of the University of Pennsylvania), Rebecca L. Olin(University of California, San Francisco), Tsiporah B. Shore(Cornell University), Celalettin Üstün(Rush University Medical Center), Jaime M. Preussler(National Marrow Donor Program), Linda J. Burns(University of Minnesota System), Dianna S. Howard(Atrium Health Wake Forest Baptist), Lohith Gowda(Yale Cancer Center), Lori Muffly(Stanford University), Cesar Rodriguez(Wake Forest University), Zeina Al‐Mansour(University of Massachusetts Chan Medical School)
Cited by 6
Related Papers
Gilteritinib or Chemotherapy for Relapsed or Refractory <i>FLT3</i> -Mutated AML
|New England Journal of Medicine|2019|1.3k
The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation
|Blood|2014|880
Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation
|New England Journal of Medicine|2020|739
Current Use of and Trends in Hematopoietic Cell Transplantation in the United States
|Transplantation and Cellular Therapy|2020|718